HIV

Dementia is one of the most prevalent complications among patients with late-stage HIV.

Antiretrovirals may increase vulnerability to syphilis in males with HIV.

Successful treatment with buprenorphine is crucial for patients with opioid use disorder.

South African Pharmacy Council lifts ban preventing pharmacies from selling DIY HIV test kits.

Sale of Panretin gel tubes approved in the United States due to a drug shortage as a result of a manufacturing issue.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Naturally-occurring antibodies that fight HIV open new avenues for research.

Unprotected sexual exposure to HIV does not necessarily lead to infection.

Benefits of ART for maternal health and prevention of perinatal transmission outweigh risks in mothers with HIV.

Sexually transmitted diseases (STDs) can be silent destructors. Patients may be unknowingly spreading infections or afraid to discuss them due to their sensitive nature.

Beneficial effects seen in blocking the immune response against HIV.

HIV treatment guidelines typically do not address specific characteristics for gay, bisexual, and men who have sex with men.

Company seeks to leverage technologies to address unmet needs.

National and global HIV guidelines recommend initiating antiretroviral therapy in all patients, regardless of CD4 count.

In HIV treatment, national and global guidelines recommend initiating antiretroviral therapy (ART) in all patients, regardless of CD4 count.

Low baseline vitamin D deficiency may decrease the effectiveness of rosuvastatin in adults with HIV.

A study published in a recent issue of the Journal of Acquired Immune Deficiency Syndromes demonstrates that low baseline vitamin D deficiency may decrease the effectiveness of rosuvastatin in adults with HIV.

Scientists solve structural details of HIV machinery.

Antenatal ART significantly lowered early mother-to-child HIV transmission rates.

HIV drug trial will evaluate cabotegravir’s performance as a pre-exposure prophylaxis.

The Aptima HIV-1 Quant assay will significantly cut lab times.

Combination treatment methods to cure HIV may have harmful side effects.

Certain protease inhibitors linked to cognitive issues.

HIV resistance may necessitate more costly therapies for third-line treatment.